Outlook Therapeutics’ Positive NORSE THREE Safety Data Presented at 2021 American Society of Retina Specialists for ONS-5010 Ophthalmic Bevacizumab
Strong safety data from NORSE THREE registration trial consistent with other trials for ONS-5010 and in…